v2.3.0.15
Segment And Geographic Information
9 Months Ended
Sep. 30, 2011
Segment And Geographic Information [Abstract] 
Segment And Geographic Information

10. SEGMENT AND GEOGRAPHIC INFORMATION

The Company considers reporting segments in accordance with FASB ASC 280, "Segment Reporting." The Company develops, manufactures, and sells devices designed primarily for the surgical ablation of cardiac tissue and systems designed for the exclusion of the left atrial appendage. These devices are developed and marketed to a broad base of medical centers in the United States and internationally. Management considers all such sales to be part of a single reportable segment.

Geographic revenue was as follows:

 

     Three Months Ended September 30,      Nine Months Ended September 30,  
     2011      2010      2011      2010  

United States

    $ 11,757,639       $ 11,554,449       $ 36,541,934       $ 34,449,920   

International

      3,464,429         2,918,664         11,096,778         8,167,305   
  

 

 

     

 

 

     

 

 

     

 

 

  

Total

    $ 15,222,068       $ 14,473,113       $ 47,638,712       $ 42,617,225   
  

 

 

     

 

 

     

 

 

     

 

 

  

Substantially all of the Company's long-lived assets are located in the United States.